Literature DB >> 10471581

Influence of cefodizime on pulmonary inflammatory response to heat-killed Klebsiella pneumoniae in mice.

Y Bergeron1, A M Deslauriers, N Ouellet, M C Gauthier, M G Bergeron.   

Abstract

Encapsulated Klebsiella pneumoniae strains frequently induce fatal nosocomial pneumonia. Cefodizime (CEF) as an antibiotic is suspected to enhance host resistance against various microbial invasions through interactions with bacteria and host cells. To investigate the influence of CEF on the pulmonary response to Klebsiella that does not merely result from direct bacterial clearance by the drug, we inoculated mice with heat-killed fluorescein isothiocyanate-labeled K. pneumoniae. CEF upregulated (P < 0.01) the early Klebsiella-induced secretion of tumor necrosis factor alpha, as well as the number (P < 0.01) and phagocytic efficacy (P < 0.001) of alveolar macrophages. By contrast, the late polymorphonuclear neutrophil recruitment (P < 0.05) and levels of interleukin-1 alpha (IL-1alpha) (P < 0.05) and IL-6 (P < 0.05) were reduced. The stimulation of an early immune response by CEF followed by late reduction in inflammation may be beneficial against bacterial pneumonia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471581      PMCID: PMC89463     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

Review 1.  Cefodizime as a biological response modifier: a review of its in-vivo, ex-vivo and in-vitro immunomodulatory properties.

Authors:  M T Labro
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

Review 2.  Pharmacokinetics of cefodizime: a review of the data on file.

Authors:  J Barré
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

3.  In vitro and ex vivo enhancement of nonspecific phagocytosis by cefodizime.

Authors:  A Fietta; C Bersani; R Bertoletti; F M Grassi; G G Grassi
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

4.  Stimulatory effect of cefodizime on macrophage-mediated phagocytosis.

Authors:  K Oishi; K Matsumoto; M Yamamoto; T Morito; T Yoshida
Journal:  J Antibiot (Tokyo)       Date:  1989-06       Impact factor: 2.649

5.  Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity.

Authors:  M T Labro; N Amit; C Babin-Chevaye; J Hakim
Journal:  J Antimicrob Chemother       Date:  1987-03       Impact factor: 5.790

Review 6.  Klebsiella pulmonary infections: occurrence at one medical center and review.

Authors:  J L Carpenter
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

7.  Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence.

Authors:  P Domenico; D L Diedrich; D C Straus
Journal:  Can J Microbiol       Date:  1985-05       Impact factor: 2.419

8.  Cefodizime host-defence enhancement: considerations of dose-response relationships in healthy volunteers.

Authors:  G Gialdroni Grassi; P M Shah
Journal:  Infection       Date:  1992       Impact factor: 3.553

9.  Immunological evaluation of cefodizime: a unique molecule among cephalosporins.

Authors:  M T Labro
Journal:  Infection       Date:  1992       Impact factor: 3.553

10.  Cefodizime, an aminothiazolyl cephalosporin. IV. Influence on the immune system.

Authors:  M Limbert; R R Bartlett; G Dickneite; N Klesel; H U Schorlemmer; G Seibert; I Winkler; E Schrinner
Journal:  J Antibiot (Tokyo)       Date:  1984-12       Impact factor: 2.649

View more
  4 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.

Authors:  Roland Nau; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia.

Authors:  S L Poe; M Arora; T B Oriss; M Yarlagadda; K Isse; A Khare; D E Levy; J S Lee; R K Mallampalli; Y R Chan; A Ray; P Ray
Journal:  Mucosal Immunol       Date:  2012-07-11       Impact factor: 7.313

Review 4.  Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation.

Authors:  Anuradha Ray; Krishnendu Chakraborty; Prabir Ray
Journal:  Front Cell Infect Microbiol       Date:  2013-09-18       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.